Risk factor
Very high price volatility
Profitability factor
Overvalued vs peers
About
P&S Robotics Co., Ltd., a Seoul, South Korea-based company established in 2003, specializes in delivering advanced robotic system solutions to both domestic and international markets. A core offering is the Walkbot, an innovative robot-assisted medical device designed for rehabilitation training of patients with impaired locomotion due to conditions such as stroke, spinal cord injury, brain tumors, multiple sclerosis, and cerebral palsy. The company's product lineup further includes Walkbot_G, a robot-assisted rehabilitation training system tailored for adults and pediatric patients experiencing neurological or musculoskeletal impairments, along with Walkbot_K, specifically engineered for children between 86cm and 148cm in height. Operating until recently as P&S Mechanics Co Ltd, the company is slated to officially adopt the name P&S Robotics Co., Ltd. in June 2025.
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. Specifically, the stock is fairly valued on P/E, overvalued on EV/EBITDA, o